December 30, 2015

DSN senior editor Michael Johnson examines the sales activity in diet and weight loss, and VMS categories, highlighting new products that are transforming OTC in this multi-page report.

December 8, 2015

DSN senior editor Michael Johnson examines the sales activity in switch products, OTC manufacturers and the VMS category, highlighting new products that are transforming OTC in this multi-page report.

November 11, 2015

DSN senior editor Michael Johnson examines in-depth sales activity in the diabetes, diagnostics and probiotics categories, highlighting new products that are transforming OTC in this multi-page report.

October 13, 2015

DSN contributing editor Richard Monks examines in-depth sales activity in the digestive and analgesic categories, highlighting new products that are transforming OTC in this multi-page report.

September 18, 2015

The Centers for Disease Control and prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works. 

September 16, 2015

With Boiron USA’s Arnicare Gel firmly established as one of the external analgesics category’s bestselling products, the company recently extended the line to include Arnicare Cream.

September 11, 2015

DSN contributing editor Richard Monks examines in-depth sales activity in the homeopathy and vitamins, minerals and supplements categories, highlighting new products that are transforming OTC in this multi-page report.

September 2, 2015

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

August 20, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the analgesics, digestives, VMS, cough-cold, sleep and first aid categories, highlighting new products that are transforming OTC in this multi-page report.

July 15, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the intimacy health and sleep categories, highlighting new products that are transforming OTC in this multi-page report.

June 22, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the sleep category in this multi-page report, which includes a Q&A with Procter & Gamble's Dave Tomasi.

June 15, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the sleep, VMS and anti-itch categories, highlighting new products that are transforming OTC in this multi-page report.

March 4, 2015

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

February 3, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the cough-cold categories, highlighting new products that are transforming OTC in this multi-page report.

January 5, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the vitamins, minerals and supplements and diet aid categories, highlighting new products that are transforming OTC in this multi-page report.

December 11, 2014

External analgesics is a category replete with growth brands with a base of $497.8 million across total U.S. multi-outlets, and more than 8.1% in growth for the 52 weeks ended Sept. 7, according to IRI data.

December 5, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics, vitamins, allergy/cold/sinus medications, and incontinence, highlighting new products that are transforming OTC in this multi-page report.

November 13, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in blood-pressure monitoring kits and blood-glucose meters, highlighting new products that are transforming OTC in this multi-page report.

October 21, 2014

Over-the-counter painkillers and anti-inflammatory drugs may also be effective in the treatment of people suffering from depression.

 

October 10, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics and digestives, highlighting new products that are transforming OTC in this multi-page report.

September 30, 2014

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain. 

August 20, 2014

The lion’s share of the analgesics business may be in internal analgesics — sales of which totaled $3.6 billion, up 1.1% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI — but it’s alternative pain relievers that may represent the growth opportunity.

August 20, 2014

Who is the alternative analgesic pain consumer? “The majority of these people [in search of external pain relief] have chronic pain and are already taking prescriptions and using multiple methods of pain relief,” said Jenny McLaughlin, product manager for Walh Therapeutic Massagers. “Our research shows people are coming into the health-and-wellness area once a month.”